This work was done at the Matthew J. Ryan Veterinary Hospital of the University of Pennsylvania.
Effect of NT-pro-BNP Assay on Accuracy and Confidence of General Practitioners in Diagnosing Heart Failure or Respiratory Disease in Cats with Respiratory Signs
Article first published online: 28 MAR 2012
Copyright © 2012 by the American College of Veterinary Internal Medicine
Journal of Veterinary Internal Medicine
Volume 26, Issue 3, pages 542–546, May-June 2012
How to Cite
Singletary, G.E., Rush, J.E., Fox, P.R., Stepien, R.L. and Oyama, M.A. (2012), Effect of NT-pro-BNP Assay on Accuracy and Confidence of General Practitioners in Diagnosing Heart Failure or Respiratory Disease in Cats with Respiratory Signs. Journal of Veterinary Internal Medicine, 26: 542–546. doi: 10.1111/j.1939-1676.2012.00916.x
This study was presented as a scientific abstract in oral form at the 2011 ACVIM Forum in Denver, CO.
- Issue published online: 2 MAY 2012
- Article first published online: 28 MAR 2012
- Manuscript Accepted: 21 FEB 2012
- Manuscript Revised: 31 JAN 2012
- Manuscript Received: 3 NOV 2011
- Congestive heart failure;
- Natriuretic peptides
N-terminal pro-B-type natriuretic peptide (NT-proBNP) can distinguish congestive heart failure (CHF) from primary respiratory disease in cats with respiratory signs with approximately 90% diagnostic accuracy, but the additive benefit of NT-proBNP to improve the diagnosis obtained from conventional testing in individual cases remains unknown.
NT-proBNP will improve the diagnostic accuracy and confidence of general practice veterinarians in assessing cats with respiratory signs.
Ten cats with respiratory signs.
History, physical examination, thoracic radiographs, electrocardiogram (ECG), and biochemical analysis of 10 cats presented to the University of Pennsylvania or Tufts University with a history of respiratory signs were evaluated by 50 general practice veterinarians using an online survey tool. Participants were asked to provide (1) diagnosis of CHF or primary respiratory disease, and (2) level of confidence in their diagnosis (1, lowest to 10, highest) before and after disclosure of NT-proBNP results. Diagnoses (CHF, n = 5; primary respiratory, n = 5) were compared to the gold standard defined as consensus opinion of 3 board-certified cardiologists blinded to the NT-proBNP results.
Overall correctness of the practitioners was 69.2%, and significantly increased after practitioners were provided NT-proBNP results (87.0%, P = .0039). Median practitioner confidence before NT-proBNP disclosure was 6 (IQR, 5–8) and significantly increased after disclosure (8; IQR, 6–10; P = .0039).
These data indicate a relatively low accuracy and level of confidence in the diagnosis of feline respiratory signs. Use of NT-proBNP assay in conjunction with conventional evaluation by general practitioners significantly improved their diagnostic accuracy and confidence.